In vivo screening of interactions between glycans and immune cells

The proposed Research Plan is to evaluate the active targeting effect of glycan ligands for the delivery of conjugated lipid nanoparticles (LNPs) to human bone marrow CD34 + hematopoietic stem and pluripotent cells (HSPCs) and human peripheral blood mononuclear cells (PBMCs) such as T cells and B cells. A reporter mRNA will be formulated into LNPs with or without glycan ligand conjugation. The activity of these LNPs will be assessed both in vitro and in vivo.

Faculty Supervisor:

Matthew Macauley;Ratmir Derda

Student:

Partner:

48 Hour DIscovery

Discipline:

Life Sciences

Sector:

Professional, scientific and technical services

University:

University of Alberta

Program:

Accelerate

Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects